Half-year report · HY
4554.TEDINET S100Y2Z6
Period2025-10-01 → 2026-03-31
Filed2026-05-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥29.7bn | 2025-10-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥51.7bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥24.1bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | ¥4.4bn | 2025-10-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥2.3bn | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥4.3bn | 2025-10-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.5bn | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.2bn | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥683m | 2025-10-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.8bn | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥713m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.0bn | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥713m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥1.3bn | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥97.9bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥93.4bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥92.7bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥46.6bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥46.5bn | at 2025-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥51.4bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥46.9bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥45.7bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.9bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.2bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.9bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.2bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.6bn | at 2024-09-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥4.1bn | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.8bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.0bn | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.2bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.8bn | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.4bn | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥954m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.8bn | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥28.75 | 2025-10-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥122.94 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.83 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 52.4% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.2% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.3% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 479
| Item | Context | Value | Unit |
|---|---|---|---|
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)富士製薬工業株式会社 | |
| Address of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)東京都千代田区三番町５番地７ | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Notes changes in accounting policies (text) | InterimDuration | Text · Plus | |
| Notes additional information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Impairment losses (text) | InterimDuration | Text · Plus | |
| Notes regarding loss on valuation of investment securities (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | InterimDuration | Original text (Japanese)当社グループ（当社及び連結子会社）は、医薬品事業の単一セグメントであるため、記載を省略しております。 | |
| Notes revenue recognition semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |